-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, I216jdr6GKfBUN61nRXc++FXNWEQhXsZNbSlDTqHZIdxT7rd6uPSqD/e+n6jSTo5 moGbEqpJ3jj/k5zNVQ5BgQ== 0000950144-01-504697.txt : 20010723 0000950144-01-504697.hdr.sgml : 20010723 ACCESSION NUMBER: 0000950144-01-504697 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20010705 ITEM INFORMATION: ITEM INFORMATION: FILED AS OF DATE: 20010720 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IVAX CORP /DE CENTRAL INDEX KEY: 0000772197 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 161003559 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: SEC FILE NUMBER: 001-09623 FILM NUMBER: 1685456 BUSINESS ADDRESS: STREET 1: 4400 BISCAYNE BLVD CITY: MIAMI STATE: FL ZIP: 33137 BUSINESS PHONE: 3055756000 MAIL ADDRESS: STREET 1: 4400 BISCAYNE BOULEVARD CITY: MIAMI STATE: FL ZIP: 33137 FORMER COMPANY: FORMER CONFORMED NAME: IVAX CORP DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: IVACO INDUSTRIES INC DATE OF NAME CHANGE: 19871213 FORMER COMPANY: FORMER CONFORMED NAME: INLAND VACUUM INDUSTRIES INC DATE OF NAME CHANGE: 19870611 8-K 1 g70618e8-k.txt IVAX, CORP 1 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 5, 2001 Commission File Number 1-09623 IVAX CORPORATION Florida 16-1003559 - ------------------------------- ------------------- (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) 4400 Biscayne Boulevard, Miami, Florida 33137 --------------------------------------------------- (Address of principal executive offices) (Zip Code) (305) 575-6000 ---------------------------------------------------- (Registrant's telephone number, including area code) 2 ITEM 2 - ACQUISITION OR DISPOSITION OF ASSETS On May 31, 2001 IVAX Corporation launched a tender offer in Chile for all of the outstanding shares of Laboratorio Chile S.A., and simultaneously launched a tender offer in the United States for all of the outstanding American Depository Shares ("ADSs") and all of the outstanding shares of Laboratorio Chile held by U.S. holders. On July 6, 2001, IVAX announced the successful completion of the tender offers and its acceptance of all validly tendered shares and ADSs of Laboratorio Chile S.A., representing approximately 99.6% of the outstanding shares, including shares represented by ADSs. IVAX purchased shares of common stock for US$1.25 per share and ADSs for US$25.00 per ADS. The aggregate purchase price of approximately $394,000,000 was paid from IVAX' cash on hand. Laboratorio Chile was, at the time of purchase, the largest Chilean pharmaceutical company in revenue terms and also among the major pharmaceutical companies in Argentina and Peru. Laboratorio Chile manufactures, markets and sells a broad line of more than 900 branded and brand equivalent products in Chile, Argentina and Peru. Its main products are to treat respiratory and infectious diseases, but it also has strong franchises with cardiovascular, neurological and gynecological products. ITEM 7 - FINANCIAL STATEMENTS AND EXHIBITS The financial statements required by this item will be filed no later than 60 days after the date that the initial report on Form 8-K must be filed. 2 3 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. IVAX CORPORATION Date: July 20, 2001 By: /s/ Thomas E. Beier ------------------------------------ Thomas E. Beier Senior Vice President-Finance Chief Financial Officer 3 -----END PRIVACY-ENHANCED MESSAGE-----